ClinicalTrials.Veeva

Menu

A-prf,Nanochitosan Combined With A-prf Compared to Chitosan for Symptomatic Irreversible Pulpitis of Mature Teeth

F

Future University in Egypt

Status

Enrolling

Conditions

Pulpitis - Irreversible

Treatments

Procedure: PULPOTOMY OF MATURE PERMENANT TEETH

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Clinical and radiographic assessment of A-prf,A-prf combined with nanochitosan compared to chitosan for symptomatic irreversible pulpits in lower permanent first molar

Full description

3 groups are allocated using : Aprf Aprf combined with nanochitosan Chitosan

Each group will be subjected to tests:

Tooth sensibility via EPT (electrical pulp tester)and thermal test Radiolucency in digital radiograph Pain in NRS(6-12-24-72h)for 1 week

Enrollment

30 estimated patients

Sex

All

Ages

15 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients suffering from Symptomatic irreversible pulpitis in mature mandibular molars only will be involved.

    • Patients of either gender aged from 15-30.
    • Tooth should give positive response to cold test.
    • Haemostasias should be achieved after total pulpotomy.
    • The tooth is restorable and free from advanced periodontal disease, cracks and splits.
    • Patients should be free from any systemic disease that may affect normal healing and predictable outcome.
    • Patients who will agree to the consent and will commit to follow-up period.
    • Patients with mature root.
    • Patients with no internal or external resorption and no periapical lesions.
    • Soft tissues around the tooth are normal with no swelling or sinus tract.

Exclusion criteria

  • Patients with immature roots.

    • Haemostasias after 10 minutes can not be controlled after total pulpotomy
    • Patients with any systemic disease that may affect normal healing.
    • Patients with periapical lesions or infections.
    • Pregnant females.
    • Patients who could/would not participate in a 6 months follow-up.
    • Patients with fistula or swelling
    • Patients with necrotic pulp.
    • Patients with old age.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

30 participants in 3 patient groups

Advanced Platelet rich fibrin,A-prf,A-PRF scaffold
Experimental group
Description:
A-PRF will be prepared according to Choukroun's technique by drawing whole blood from the median cubital vein into a 10 ml plain plastic test tubes (non-citrated) without the addition of an anticoagulant reagent . To prevent the blood from coagulating, it will be centrifuged immediately using a table top centrifuge at 1500 rpm for 14 minute.
Treatment:
Procedure: PULPOTOMY OF MATURE PERMENANT TEETH
A-prf mixed with nano chitosan
Experimental group
Description:
A-PRF will be prepared according to Choukroun's technique by drawing whole blood from the median cubital vein into a 10 ml plain plastic test tubes (non-citrated) without the addition of an anticoagulant reagent . To prevent the blood from coagulating, it will be centrifuged immediately using a table top centrifuge at 1500 rpm for 14 minute then mixed with nanochitosan
Treatment:
Procedure: PULPOTOMY OF MATURE PERMENANT TEETH
chitosan
Experimental group
Description:
he access cavity will be prepared up to the level of pulp chamber floor using sterile round diamond bur size 1 in high-speed hand piece with coolant.Once the pulp has been reached, a sharp sterile excavator should be used to remove the pulp tissue to the level of the radicular/root canal orifices then chitosan will be applied
Treatment:
Procedure: PULPOTOMY OF MATURE PERMENANT TEETH

Trial contacts and locations

1

Loading...

Central trial contact

mai S abdelwahed, Bachelor; Hala s abdelwahed, student

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems